6533b853fe1ef96bd12acb71

RESEARCH PRODUCT

Characterization of prejunctional muscarinic autoreceptors in the guinea-pig trachea

R. SchneiderH. SiefkenD. WolfGianluigi D'agostinoHeinz Kilbinger

subject

medicine.medical_specialtyGuinea PigsIn Vitro TechniquesBiologyCholinechemistry.chemical_compoundInternal medicineMuscarinic acetylcholine receptormedicineMethoctramineAnimalsReceptorPharmacologyParasympatholyticsMuscarinic acetylcholine receptor M3Muscle SmoothMuscarinic acetylcholine receptor M2Receptors MuscarinicAcetylcholineElectric StimulationTracheaEndocrinologychemistryAutoreceptormedicine.symptomAcetylcholineMuscle ContractionResearch Articlemedicine.drugMuscle contraction

description

1. The effects of ten muscarinic antagonists on electrically evoked [3H]-acetylcholine release and muscle contraction were compared in an epithelium-free preparation of the guinea-pig trachea that had been preincubated with [3H]-choline. 2. The M3-selective antagonists UH-AH 37, 4-diphenyl-acetoxy-N-piperidine methobromide and para-fluorohexahydrosiladiphenidol were more potent in reducing the contractile response than in facilitating the evoked [3H]-acetylcholine release. Hexahydrosiladiphenidol did not discriminate between pre- and postjunctional effects. The rank order of the postjunctional potencies of the ten antagonists as well as the postjunctional pA2 values obtained for hexahydrosiladiphenidol (7.95) and AQ-RA (7.08) identified the muscular receptor as an M3 subtype. 3. The M2-selective antagonists methoctramine, AF-DX 116 and AQ-RA 741 were more potent in facilitating the evoked [3H]-acetylcholine release than in inhibiting the contractile response. The increase in release by low concentrations of methoctramine, AF-DX 116 and AQ-RA 741 was paralleled by an enhancement of the stimulation-evoked contractions. 4. Comparison of the pre- and postjunctional potencies of the M1-, M2- and M3-selective antagonists suggests that autoinhibition of acetylcholine release is mediated via an 'M2-like' receptor which differs from the cardiac type M2 receptor in its relatively high affinity for hexahydrosiladiphenidol.

https://doi.org/10.1111/j.1476-5381.1991.tb09859.x